Solid pseudopapillary neoplasm of the pancreas: A retrospective single-center cohort study of 1,058 consecutive patients
Pancreatology · 2026
DOI: 10.1016/j.pan.2026.07.002 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pancreatology, 2026. Verfasst von Yi Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College,…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Papillary. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare, low-grade malignant tumor, predominantly affecting young women. Although the overall prognosis of SPN is good, the understanding of its pathophysiological characteristics and the selection of treatment strategies remain insufficient. METHODS: A retrospective analysis of 1058 consecutive patients with pathologically confirmed SPN was performed at a single institution. Clinicopathological characteristics, immunohistochemical profiles, targeted sequencing data, and overall survival were systematically evaluated. RESULTS: The median age of the patients at diagnosis was 33 years, with females being the majority (78.1%). Most tumors were located in the body/tail (70.2%), larger than 3 cm (61.9%), while invasive features such as vascular invasion (1.6%), nerve invasion (7.0%), and lymph node metastasis (0.7%) were rare. Early-stage (stage I, II) patients were more common (99.1%). In recent years, the surgical procedures have significantly shifted towards minimally invasive and parenchyma-sparing surgery. The prognosis of SPN was excellent, with a 5-year survival of 97.9%. Molecular analysis revealed nearly universal CTNNB1 mutations (97%). High expression of progesterone receptor (PR, 97.2%) and low expression of estrogen receptor (ER, 7.7%) supported hormone dependence. CONCLUSIONS: This large single-center cohort study confirms that SPN is a tumor with low malignant potential, and identifies the key clinicopathological and molecular factors associated with malignant features. Different hormone receptor profiles provide a theoretical basis for exploring hormone receptor-targeted therapy for advanced patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Shanghai Pancreatic Cancer…
- Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Electronic address: wanglei056713@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Zhang, N., Song, Y., Xiao, Z., Liao, Y., Li, Y., Shi, Y., Wang, X., Ni, Q., Wang, L., Yu, X., & Luo, G. (2026). Solid pseudopapillary neoplasm of the pancreas: A retrospective single-center cohort study of 1,058 consecutive patients. Pancreatology. https://doi.org/10.1016/j.pan.2026.07.002
Vancouver
Liu Y, Zhang N, Song Y, Xiao Z, Liao Y, Li Y, et al. Solid pseudopapillary neoplasm of the pancreas: A retrospective single-center cohort study of 1,058 consecutive patients. Pancreatology. 2026. doi:10.1016/j.pan.2026.07.002
BibTeX
@article{Liu2026,
author = {Liu, Yi and Zhang, Nuoyan and Song, Yilin and Xiao, Zhiwen and Liao, Yina and Li, Yiying and Shi, Yang and Wang, Xinyue and Ni, Quanxing and Wang, Lei and Yu, Xianjun and Luo, Guopei},
title = {Solid pseudopapillary neoplasm of the pancreas: A retrospective single-center cohort study of 1,058 consecutive patients},
journal = {Pancreatology},
year = {2026},
doi = {10.1016/j.pan.2026.07.002}
}
EUVIMED